healthneutral
Ending the Opioid Addictionwith New Journavx Drug
Saturday, February 1, 2025
A total of 874 individuals who were facing some intense pain from surgery participated in the trials of Journavx. Participants in the trials did not know who was getting the actual medicine or who was getting a substitute, and neither the doctors nor the researchers knew who was getting what. Moreover, they also had ibuprofen as an option, which works by interfering with enzymes responsible for pain and inflammation.
The patients who received Journavx reported a significant reduction in pain. The company behind the research noted that temporary side effects. Read: temporary fertility reduction and it can also increase muscle spasms creatine, and a rash. In the mood for more? It also hampers female fertility. Female patients worried about this or experiencing it should chat with their healthcare team before taking the medication.
It is now accessible to people only that are adults. This is because it is not yet clear whether it would be safe and effective for kids, too. The FDA gives it a thumbs up. A non-addictive pain reliever that could come in handy against a world of painkillers.
Actions
flag content